Cellebrite DI (NASDAQ:CLBT) Posts Earnings Results, Misses Expectations By $0.03 EPS

Cellebrite DI (NASDAQ:CLBT) posted its quarterly earnings results on Thursday. The company reported $0.07 EPS for the quarter, missing the consensus estimate of $0.10 by ($0.03), Zacks reports. Cellebrite DI had a negative net margin of 82.28% and a positive return on equity of 122.59%. Cellebrite DI updated its FY 2025 guidance to EPS and its Q1 2025 guidance to EPS.

Cellebrite DI Trading Down 10.5 %

NASDAQ CLBT traded down $2.62 during trading hours on Thursday, reaching $22.31. The company had a trading volume of 2,473,267 shares, compared to its average volume of 1,804,066. The stock has a market capitalization of $4.59 billion, a P/E ratio of -14.41, a price-to-earnings-growth ratio of 3.72 and a beta of 1.47. The stock has a 50-day moving average of $22.57 and a 200 day moving average of $19.09. Cellebrite DI has a 1-year low of $9.22 and a 1-year high of $26.30.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on CLBT. Craig Hallum raised their target price on Cellebrite DI from $23.00 to $24.00 and gave the stock a “buy” rating in a research note on Thursday, November 7th. JPMorgan Chase & Co. upped their price objective on shares of Cellebrite DI from $24.00 to $28.00 and gave the company an “overweight” rating in a report on Tuesday. Finally, Needham & Company LLC lifted their target price on shares of Cellebrite DI from $21.00 to $28.00 and gave the stock a “buy” rating in a research note on Wednesday, January 22nd. Eight analysts have rated the stock with a buy rating, Based on data from MarketBeat, the company presently has a consensus rating of “Buy” and a consensus target price of $22.14.

About Cellebrite DI

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft.